New Classification Criteria for Systemic Sclerosis (Scleroderma)

Rheumatic Disease Clinics of North America

Volumn 41, Issue 3, 2015, Pages 383-398

  Pope, Janet E ^a   Johnson, Sindhu R ^b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Classification criteria; Diagnosis; Performance; Scleroderma; Sensitivity; Specificity; Systemic sclerosis; Validation

Indexed keywords

AUTOANTIBODY;

CAPILLAROSCOPY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FINGER ULCER; GOLD STANDARD; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LINEAR SCLERODERMA; LUNG FUNCTION TEST; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; TELANGIECTASIA; TENOSYNOVITIS; THORAX RADIOGRAPHY; VASCULAR DISEASE; CASE REPORT; CLASSIFICATION; FEMALE; MALE; MIDDLE AGED; SJOEGREN SYNDROME;

FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 84937972834     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2015.04.003     Document Type: Review

References (36)

1. Wollheim F.A. Classification of systemic sclerosis: visions and reality. Rheumatology (Oxford) 2005, 44:1212-1216.
2. Muangchan C., Canadian Scleroderma Research Group, Baron M., et al. The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review. J Rheumatol 2013, 40(9):1545-1556.
3. Singh J.A., Solomon D.H., Dougados M., et al. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006, 55:348-352.
4. Masi A.T., Rodnan G., Medsger T., et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association. Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23(5):581-590.
5. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Bull Rheum Dis 1981, 31:1-6.
6. Nadashkevich O., Davis P., Fritzler M.J. A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 2004, 10(11):CR615-CR621.
7. LeRoy E.C., Medsger T.A. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001, 28(7):1573-1576.
8. Johnson S.R., Goek O.N., Singh-Grewal D., et al. Classification criteria in rheumatic diseases. A review of methodologic properties. Arthritis Rheum 2007, 57(7):1119-1133.
9. Lonzetti L.S., Joyal F., Raynauld J.P., et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001, 44(3):735-736.
10. Hachulla E., Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 2011, 40(2):78-83.
11. Walker J.G., Pope J., Baron M., et al. The development of systemic sclerosis classification criteria. Clin Rheumatol 2007, 26(9):1401-1409.
12. LeRoy E.C., Black C., Fleischmajer R., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15(2):202-205.
13. Hudson M., Taillefer S., Steele R., et al. Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007, 25(5):754-757.
14. Fransen J., Johnson S.R., van den Hoogen F., et al. Items for developing revised classification criteria in systemic sclerosis: results of a consensus exercise. Arthritis Care Res 2012, 64:351-357.
15. Johnson S.R., Fransen J., Khanna D., et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res 2012, 64(3):358-367.
16. Johnson S.R., Naden R.P., Fransen J., et al. Scleroderma classification criteria: developing methods for multi-criteria decision analysis using 1000 minds. J Clin Epidemiol 2014, 67(6):706-714.
17. van den Hoogen F., Khanna D., Fransen J., et al. 2013 classification criteria for systemic sclerosis: an American college of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2013, 72:1747-1755.
18. van den Hoogen F., Khanna D., Fransen J., et al. 2013 classification criteria for systemic sclerosis: an American College Of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2013, 65:2737-2747.
19. Felson D.T., Anderson J.J. Methodologic and statistical approaches to criteria development in rheumatic diseases. Baillieres Clin Rheumatol 1995, 9:253-266.
20. Coulter C., Baron M., Pope J.E. A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databases. Clin Exp Rheumatol 2013, 31(2 Suppl 76):24-30.
21. Hoffmann-Vold A.-M., Gunnarsson R., Garen T., et al. Performance of the 2013 ACR/EULAR classification criteria for systemic sclerosis (SSc) in large, well defined cohorts of SSc and mixed connective tissue disease. J Rheumatol 2015, 42:60-63.
22. Alhajeri H., Hudson M., Fritzler M., Canadian Scleroderma Research Group (CSRG), et al. Evaluation of the new ACR/EULAR criteria for the classification of systemic sclerosis in the Canadian Scleroderma Research Group cohort. J Rheumatol 2014, 41:1530-1531.
23. Yaqub A., Chung L., Fiorentino D., et al. Validation of the ICD-CM-9 code for systemic sclerosis using updated ACR/EULAR classification criteria. Arthritis Rheum 2013, 65:S772-S773.
24. Andréasson K., Saxne T., Bergknut C., et al. Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria. Ann Rheum Dis 2014, 73(10):1788-1792.
25. Wang J., Assassi S., Guo G., et al. Clinical and serological features of systemic sclerosis in a Chinese cohort. Clin Rheumatol 2013, 32(5):617-621.
26. Hashimoto A., Endo H., Kondo H., Hirohata S. Clinical features of 405 Japanese patients with systemic sclerosis. Mod Rheumatol 2012, 22(2):272-279.
27. Graf S.W., Hakendorf P., Lester S., et al. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome. Int J Rheum Dis 2012, 15(1):102-109.
28. Müller Cde S., Paiva Edos S., Azevedo V.F., et al. Autoantibody profile and clinical correlation in a group of patients with systemic sclerosis in southern Brazil. Rev Bras Reumatol 2011, 51(4):314-318. 323-4.
29. Admou B., Arji N., Seghrouchni F., et al. Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases). Ann Biol Clin (Paris) 2007, 65(3):291-297.
30. Pradhan V., Rajadhyaksha A., Nadkar M., et al. Clinical and autoimmune profile of scleroderma patients from Western India. Int J Rheumatol 2014, 2014:983781.
31. Gottschalk P., Vásquez R., López P.D., et al. Scleroderma in the Caribbean: characteristics in a Dominican case series. Rheumatol Clin 2014, 10(6):373-379.
32. Valentini G., Marcoccia A., Cuomo G., et al. The concept of early systemic sclerosis following 2013 ACR/EULAR criteria for the classification of systemic sclerosis. Curr Rheumatol Rev 2014, 10(1):38-44.
33. Johnson S.R., Feldman B.M., Hawker G.A. Classification criteria for scleroderma subsets. J Rheumatol 2007, 34:1855-1863.
34. Matucci-Cerinic M., Bellando-Randone S., Lepri G., et al. Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. Ann Rheum Dis 2013, 72(3):319-321.
35. Pope J.E. SSc classification: a rose by any other name would smell as sweet?. J Rheumatol 2015, 42(1):11-13.
36. Varga J., Hinchcliff M. Connective tissue diseases: systemic sclerosis: beyond limited and diffuse subsets?. Nat Rev Rheumatol 2014, 10(4):200-202.